These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 8656753)

  • 21. Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
    Kontio M; Jokinen S; Paunio M; Peltola H; Davidkin I
    J Infect Dis; 2012 Nov; 206(10):1542-8. PubMed ID: 22966129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.
    Al-Sukaiti N; Reid B; Lavi S; Al-Zaharani D; Atkinson A; Roifman CM; Grunebaum E
    J Allergy Clin Immunol; 2010 Oct; 126(4):868-9. PubMed ID: 20810153
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
    Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
    Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Initial results and evaluation of igg antibody levels for measles, mumps, rubella and chickenpox viruses in young adults born in 1989].
    Sadowska-Galera M
    Przegl Epidemiol; 2009; 63(3):363-7. PubMed ID: 19899592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.
    Kakoulidou M; Ingelman-Sundberg H; Johansson E; Cagigi A; Farouk SE; Nilsson A; Johansen K
    Vaccine; 2013 Jan; 31(4):711-7. PubMed ID: 23174196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relation between serologic verification and anamnestic data on the principal virus diseases of infancy].
    Profeta ML; Ferrante P; Mendogni D
    Boll Ist Sieroter Milan; 1987; 66(5):367-76. PubMed ID: 3449098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of antibody to measles, mumps, and rubella by age.
    Morgan-Capner P; Wright J; Miller CL; Miller E
    BMJ; 1988 Sep; 297(6651):770-2. PubMed ID: 3142541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Seroprotection against hepatitis A, measles, rubella, and parotiditis in an urban school population].
    Gil A; González A; Dal-Ré R; Aguilar L; Rey Calero J
    Med Clin (Barc); 1991 May; 96(18):681-4. PubMed ID: 1649358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of young offenders to measles and rubella: an antibody prevalence study using oral fluid samples.
    Gill J; Aston R; Vyse AJ; White JM; Greenwood A
    Commun Dis Public Health; 2002 Dec; 5(4):314-7. PubMed ID: 12564248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for undervaccination against measles in a large sample of preschool children from rural Bavaria.
    Zucs AP; Crispin A; Eckl E; Weitkunat R; Schlipköter U
    Infection; 2004 Jun; 32(3):127-33. PubMed ID: 15188070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
    Samoilovich EO; Kapustik LA; Feldman EV; Yermolovich MA; Svirchevskaya AJ; Zakharenko DF; Fletcher MA; Titov LP
    Cent Eur J Public Health; 2000 Aug; 8(3):160-3. PubMed ID: 10965439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
    Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Responses to triple viral and tetanus vaccination in HIV-infected children].
    Echeverría Lecuona J; Aldamiz-Echevarría Azuara L; Cilla Eguiluz G; Pérez Trallero E
    An Esp Pediatr; 1996 Apr; 44(4):317-20. PubMed ID: 8849078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.